Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.06% Nasdaq Down 0.01%
Streaming
Ticker Tape: On

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS

28.98 Up 0.92(3.28%) May 24, 4:00PM EDT|After Hours : 28.80 Down 0.18 (0.62%) May 24, 5:00PM EDT

Add to Portfolio
Prev Close:28.06
Open:28.84
Bid:28.30 x 2000
Ask:30.65 x 100
1y Target Est:30.75
Beta:1.79
Next Earnings Date: 5-Aug-13ALNY Earnings announcement
Day's Range:28.47 - 29.07
52wk Range:9.94 - 29.07
Volume:384,050
Avg Vol (3m):423,561
Market Cap:1.80B
P/E (ttm):N/A
EPS (ttm):-1.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALNY

Comparison

Symbol% ChgMkt Cap
ALNYUp 3.28%1.80B
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 1.59%11.96B
SUNPHARMA.NSDown 3.69%1.00T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-1.29
Quarterly EPS Est (Jun-13) :-0.34
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):3.30

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback